These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

847 related items for PubMed ID: 19520246

  • 1. Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management.
    Yeh ET, Bickford CL.
    J Am Coll Cardiol; 2009 Jun 16; 53(24):2231-47. PubMed ID: 19520246
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Disorders of the cardiovascular system during treatment of oncologic diseases].
    Elbl L.
    Vnitr Lek; 2002 Jul 16; 48(7):619-25. PubMed ID: 12197403
    [Abstract] [Full Text] [Related]

  • 5. Insights into cardiovascular side-effects of modern anticancer therapeutics.
    Stortecky S, Suter TM.
    Curr Opin Oncol; 2010 Jul 16; 22(4):312-7. PubMed ID: 20535072
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cardiovascular effects of systemic cancer treatment.
    Senkus E, Jassem J.
    Cancer Treat Rev; 2011 Jun 16; 37(4):300-11. PubMed ID: 21126826
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Predicting and preventing the cardiotoxicity of cancer therapy.
    Anderson B, Sawyer DB.
    Expert Rev Cardiovasc Ther; 2008 Aug 16; 6(7):1023-33. PubMed ID: 18666852
    [Abstract] [Full Text] [Related]

  • 10. [Cardiotoxicity of cancer therapy].
    Marek J, Linhart A, Rucklová Z, Haber J, Korínek J.
    Vnitr Lek; 2011 May 16; 57(5):472-84. PubMed ID: 21695928
    [Abstract] [Full Text] [Related]

  • 11. Chemotherapy-related cardiotoxicity.
    Aggarwal S, Kamboj J, Arora R.
    Ther Adv Cardiovasc Dis; 2013 Apr 16; 7(2):87-98. PubMed ID: 23487044
    [Abstract] [Full Text] [Related]

  • 12. Cardiovascular emergencies in the cancer patient.
    Keefe DL.
    Semin Oncol; 2000 Jun 16; 27(3):244-55. PubMed ID: 10864214
    [Abstract] [Full Text] [Related]

  • 13. Prospective surveillance and management of cardiac toxicity and health in breast cancer survivors.
    Schmitz KH, Prosnitz RG, Schwartz AL, Carver JR.
    Cancer; 2012 Apr 15; 118(8 Suppl):2270-6. PubMed ID: 22488701
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Cardiovascular complications of chemotherapy].
    Tovena DM, Inzoli A, Donato G, Gazzaniga P, Bianchessi C.
    G Ital Cardiol (Rome); 2012 Oct 15; 13(10 Suppl 2):165S-170S. PubMed ID: 23096398
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacological foundations of cardio-oncology.
    Minotti G, Salvatorelli E, Menna P.
    J Pharmacol Exp Ther; 2010 Jul 15; 334(1):2-8. PubMed ID: 20335321
    [Abstract] [Full Text] [Related]

  • 18. [Cardiovascular morbidity in patients after treatment for testicular cancer].
    Valentová M, Mladosievicová B.
    Vnitr Lek; 2010 Sep 15; 56(9):915-9. PubMed ID: 21137178
    [Abstract] [Full Text] [Related]

  • 19. Chemotherapy-induced cardiotoxicity: detection, prevention, and management.
    Truong J, Yan AT, Cramarossa G, Chan KK.
    Can J Cardiol; 2014 Aug 15; 30(8):869-78. PubMed ID: 25064580
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.